Skip to Content

IL 3584 (Theophylline extended-release 100 mg)

Pill imprint IL 3584 has been identified as Theophylline extended-release 100 mg.

Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Theophylline extended-release 100 mg IL 3584
Theophylline extended-release 100 mg IL 3584
Theophylline extended-release
IL 3584
100 mg
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Inwood Laboratories Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00182-1589 Goldline Laboratories Inc
00904-1610 Major Pharmaceuticals
00456-4310 Forest Laboratories, Inc.
00490-0080 Southwood Pharmaceuticals Inc (repackager)
49999-0921 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.